<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE308nnn/GSE308330/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Genomics</omics_type><species>Homo sapiens</species><gds_type>Genome binding/occupancy profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308330</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Super-enhancer formation in scirrhous gastric cancer-associated fibroblasts, and its presence in fibroblasts in non-cancerous tissues (1)</name><description>Scirrhous gastric cancer has aggressive clinical courses and is characterized by dominating cancer-associated fibroblasts (CAFs). We here aimed to explore the molecular basis for scirrhous CAFs and their origin. Scirrhous CAFs had heavily acetylated super-enhancers, and therapeutic targeting of super-enhancers by a BET bromodomain inhibitor, mivebresib, markedly decreased their migration-promoting activity.</description><dates><publication>2026/06/10</publication></dates><accession>GSE308330</accession><cross_references><GSM>GSM9242340</GSM><GSM>GSM9242332</GSM><GSM>GSM9242333</GSM><GSM>GSM9242341</GSM><GSM>GSM9242330</GSM><GSM>GSM9242331</GSM><GSM>GSM9242342</GSM><GSM>GSM9242336</GSM><GSM>GSM9242337</GSM><GSM>GSM9242334</GSM><GSM>GSM9242335</GSM><GSM>GSM9242329</GSM><GSM>GSM9242338</GSM><GSM>GSM9242327</GSM><GSM>GSM9242328</GSM><GSM>GSM9242339</GSM><GPL>30173</GPL><GSE>308330</GSE><taxon>Homo sapiens</taxon><PMID>[42070972]</PMID></cross_references></HashMap>